Login

Urologic Oncology

Prostate cancer mortality among elderly men after discontinuing organised screening

All biochemical recurrences are equal, but some are more equal than others

Patients’ preferences for additional (cytoreductive) treatments to the prostate and metastasis in metastatic prostate cancer

How to handle the opening market in robotic surgery

Cost effectiveness of prostate cancer screening in Europe

First and second-line treatments in metastatic renal cell carcinoma

PSA screening in limbo: how low should we go?

Treatment options for renal cell carcinoma

Malignant upper urinary tract obstruction: emergency presentations and long-term outcomes

Oncological benefits of extended pelvic lymph node dissection

Anti-VEGF and PD-1 combinations in renal cell carcinoma

Intravesical instillation of chemotherapy before radical surgery for upper UTUC
Prev
Next
× UAT site